Biomarkers and Genomic Analysis

Describe the role of genomic biomarkers in diagnosis.

Genomic biomarkers can be used to identify diseases, predict disease outcomes, and assess responses to treatments.

Explain the significance of personal genomic information.

Personal genomic information provides insights into disease detection, prediction of disease outcomes, and responses to drugs or treatments.

Evaluate the methods of analyzing genomes for disease diagnosis.

Different methods include Sanger sequencing, next-generation sequencing, and DNA microarrays, each with varying costs and processing times.

How do point-of-care tests detect SNPs?

Point-of-care tests can identify single nucleotide polymorphisms (SNPs) that are associated with disease risk and treatment responses.

Define single nucleotide polymorphisms (SNPs).

SNPs are normal variations in the bases of the human genome that play a key role in disease development and treatment responses.

Discuss the concept of multifactorial inheritance.

Multifactorial inheritance refers to the phenomenon where common health diseases arise from multiple genetic and environmental factors.

Explain the historical milestones in genome sequencing from 1950 to 2010.

Key milestones include the discovery of the DNA double helix in 1950, development of Sanger sequencing in 1970, and the completion of the Human Genome Project in 2000.

What is the purpose of Genome Wide Association Studies (GWAS)?

GWAS aims to identify associations between SNPs and diseases within populations, helping to understand genetic risk factors.

Describe the advancements in DNA sequencing technology.

Advancements include the transition from Sanger sequencing to next-generation sequencing, which has reduced costs and processing times significantly.

How has the NHS utilized genomic information in medicine?

The NHS has integrated genomic information for diagnosing conditions like familial hypercholesterolemia and has established a genomic medicine service.

Describe the purpose of the 100,000 genomes project.

The 100,000 genomes project was set up in 2012 to sequence 100,000 genomes from NHS patients affected by a rare disease or cancer.

Explain the role of pharmacists in genomic medicine.

Pharmacists play a role in delivering personalized medicine, which includes gene therapy, genomic test results, and pharmacogenomic tests.

How do commercial genome sequencing kits function?

Commercial genome sequencing kits use SNP arrays to sequence specific parts of the genome where variation is known to occur or are linked to disease.

Discuss the implications of direct-to-consumer genetic testing.

Direct-to-consumer genetic testing provides information about ancestry or disease risks, but raises questions about how patients will respond to this information.

Identify the applications of genomic testing.

Genomic testing can be used for diagnosing rare diseases, identifying host genetic factors in multifactorial diseases, diagnosing infectious diseases, treating cancer, pharmacogenomics, and developing new drugs.

Define Huntington's disease and its genetic basis.

Huntington's disease is a monogenic inherited disease that causes progressive degeneration of neurons in the brain, caused by excessive CAG repeats in the huntington gene.

How is the diagnosis of Huntington's disease performed?

The diagnosis of Huntington's disease involves amplifying the huntington gene by PCR and fractionating the products by size, where the size indicates the number of CAG repeats.

Explain the ethical considerations in genomic medicine.

Ethical considerations in genomic medicine include consent, sample handling, and analysis of genetic information.

What advancements have DNA sequencing developments brought to personalized medicine?

Developments in DNA sequencing have enhanced our ability to deliver personalized medicine by allowing for more precise diagnoses and tailored treatments based on genetic information.

Discuss the potential benefits and drawbacks of direct-to-consumer genetic testing kits.

The potential benefits include increased access to genetic information and awareness of health risks, while drawbacks may involve misinterpretation of results and privacy concerns.

Describe Array Comparative Genome Hybridisation (Array CGH).

Array CGH is a technique used to diagnose diseases caused by chromosomal abnormalities, such as Down syndrome and Prader-Willi syndrome, by comparing a patient's genome to a reference genome. The fluorescence ratio indicates duplication or deletion of parts of the genome.

Explain the significance of BRCA1 and BRCA2 genetic testing.

BRCA1 and BRCA2 genetic testing identifies variants associated with breast and ovarian cancer, particularly in individuals with a strong family history of cancer. It is a predictive genetic test that helps assess the risk of developing these cancers and informs risk management strategies.

How does point-of-care testing improve genetic testing processes?

Point-of-care testing enhances genetic testing by utilizing portable technology for real-time genotyping, allowing for immediate results in clinical settings, such as tracking outbreaks of diseases like Salmonella and Ebola.

Define the role of polygenic risk scores in glaucoma diagnosis.

Polygenic risk scores aggregate the genetic contributions from multiple SNPs to indicate an individual's overall genetic risk for developing glaucoma, which is a progressive neurodegenerative disease of the optic nerve.

Do early stages of glaucoma present symptoms?

No, the early stages of glaucoma are usually asymptomatic, which often leads to a late diagnosis when significant damage has already occurred.

Explain the importance of tracking the spread of COVID-19 through genomic epidemiology.

Genomic epidemiology plays a crucial role in tracking the spread of COVID-19 by analyzing genetic variations in the virus, which helps in understanding transmission patterns and informing public health responses.

Describe the process involved in BRCA1/2 genetic testing.

The BRCA1/2 genetic testing process involves PCR amplification and DNA sequencing of the BRCA1 and BRCA2 genes to identify any variants that may indicate an increased risk of breast or ovarian cancer.

What are the challenges associated with point-of-care testing for SNPs?

Challenges include the need for direct amplification from blood samples, the development of detection methods that can differentiate between single base differences in alleles, and the interpretation of the test outcomes.

Identify the main genetic contributions to glaucoma.

The main genetic contributions to glaucoma are polygenic, with over 100 common SNPs identified through Genome-Wide Association Studies (GWAS), along with three monogenic causes: MYOC, TBK1, and OPTN, which account for only about 5% of cases.

How has mobile sequencing technology been utilized during outbreaks?

Mobile sequencing technology, such as the MinION sequencer, has been used during outbreaks like Ebola to generate whole genome sequencing data, allowing for the identification and linking of cases in real-time.

Describe the process of point-of-care testing for SNPs.

Point-of-care testing for SNPs involves using a simple fluorescent-based assay with a short probe designed to target a sequence across a single nucleotide polymorphism (SNP). The probe anneals to both alleles but dissociates at different temperatures, allowing for differentiation. HyBeaconâ„¢ probes exhibit higher fluorescence when annealed to the target sequence, and PCR amplification followed by melting or annealing curve analysis is used to distinguish between homozygous matched, homozygous mismatched, heterozygous control, and no template control.

Explain the significance of the Tm values in SNP testing.

The Tm values (melting temperatures) indicate the temperature at which the DNA probe dissociates from the target sequence. For example, in the CYP2D6*4 SNP, a Tm of 63°C suggests a strong binding to the target, while a Tm of 55°C indicates weaker binding. These differences in Tm values help in identifying the genotype of the sample.

Define HyBeaconâ„¢ probes and their role in genetic testing.

HyBeaconâ„¢ probes are specialized fluorescent probes used in genetic testing that increase fluorescence when they anneal to their target sequence. They are particularly useful in SNP detection as they allow for the differentiation of alleles based on their binding characteristics.

How does PCR amplification contribute to SNP analysis?

PCR amplification is used to increase the quantity of DNA in a sample, making it easier to analyze specific regions, such as SNPs. Following amplification, techniques like melting or annealing curve analysis can be employed to distinguish between different genotypes based on the behavior of the probes.

Do you know another example of genetic testing used for diagnostics?

An example of genetic testing used for diagnostics is the testing for BRCA1 and BRCA2 gene mutations, which are associated with an increased risk of breast and ovarian cancer.

Explain how genetic testing has improved prognosis and treatment for diseases.

Genetic testing has improved prognosis and treatment by enabling personalized medicine, allowing healthcare providers to tailor treatments based on an individual's genetic makeup. For example, identifying specific mutations can guide the choice of targeted therapies, improving outcomes and reducing adverse effects.

Describe the role of genetic factors in susceptibility to infections, such as SARS-CoV-2.

Genetic factors can influence an individual's susceptibility to infections like SARS-CoV-2 by affecting immune response, receptor binding, and overall health. Studies have identified specific genetic variations that may increase the risk of severe outcomes in infected individuals.

What is the significance of rapid draft sequencing in outbreak situations?

Rapid draft sequencing allows for quick identification and characterization of pathogens during outbreaks, such as Salmonella or Ebola. This technology enables real-time monitoring and response, helping to control the spread of infections and inform public health strategies.

How has student-centered learning been applied in the context of genetic testing?

Student-centered learning in genetic testing encourages students to actively engage with the material, such as by researching examples of genetic testing used for diagnostics and discussing their implications for patient prognosis and treatment.